logo
  • All content
  • Showcases
    • BioVox
    • Janssen Pharmaceutica
    • Turnstone
    • V-Bio Ventures
  • Topics
    • Academia
    • Diagnostics
    • Finance
    • Genetic
    • Immunology
    • Infectious diseases
    • Industry
    • Microbiology
    • Neuroscience
    • New treatments
    • Non-communicable diseases
    • Oncology
    • Plants
    • Technical innovations
    • Vision / opinion / people
  • Events
  • About
  • Contact
  • Subscribe to newsletter
  • Search

    AN INITIATIVE OF Turnstone communications logo

    V-Bio Ventures: a fresh fund with a difference

    February 24, 2021 · V-Bio Ventures
    V-Bio Ventures recently announced their second fund, with the first closing already totaling 78 million euros. As a VC fund […] Read more
    News

    Newton Biocapital invests in Flemish start-up DeuterOncology

    Brussels, Belgium, 24 February 2021 – Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and […] February 24, 2021 · Turnstone Communications
    News

    Preventive saliva test for detecting the COVID-19 virus is now available to companies and organizations

    Ghent, Belgium, 23 February 2021 – The Ghent company Biogazelle and the medical laboratory Labo Nuytinck (Ghent, Evergem), together with […] February 23, 2021 · Turnstone Communications
    News

    PharmaFluidics Announces Ultra-Sensitive Second Generation µPAC™ Technology for Unbiased Single Cell Proteomics

    Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level Ghent, Belgium, […] February 17, 2021 · Turnstone Communications
    News

    Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center

    – Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk […] February 8, 2021 · Turnstone Communications
    News

    V-Bio Ventures launches its second fund at EUR 78 million

    – First Closing of V-Bio Fund 2 is announced at EUR 78 million – V-Bio Fund 2 will ensure seamless […] February 4, 2021 · V-Bio Ventures
    News

    DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy

    Diepenbeek, Belgium – January 28, 2021 – DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for […] January 28, 2021 · Turnstone Communications
    Article

    One year of COVID-19: a look back at 2020 and where we are now

    One year on from the emergence of SARS-COV-2 in Wuhan, China, this novel coronavirus continues to devastate the world. Since […] January 27, 2021 · BioVox
    Article

    Prestigious prize for Belgian breakthrough in brain research

    Prof. Dr. Pierre Vanderhaeghen from VIB-KU Leuven has been awarded the Generet Prize for Rare Diseases for his research on […] January 27, 2021 · BioVox
    Article

    New VIB incubator gives agbiotech start-ups a chance to flourish

    In mid-2021, research institute VIB will open its brand-new agbiotech incubator. The new complex will provide entrepreneurs with access to […] January 27, 2021 · BioVox
    Article

    How to build the right team for start-up success

    One of the key ingredients to start-up success is a stellar management team. Attracting (and retaining) the right kind of […] January 27, 2021 · V-Bio Ventures
    Article

    Decades-old discoveries cause paradigm shifts in modern medicine

    Complete paradigm shifts in medicine are rare, but there have nevertheless been several major examples in the past hundred years. […] December 16, 2020 · V-Bio Ventures
    Sponsored

    The rapid evolution of Chinese biotech

    The world is smaller today than it has ever been. With the COVID-19 pandemic, we have seen the advantages of […] December 2, 2020 · Turnstone Communications
    Sponsored

    Belgian biotechs partnering with China: deals of 2020

    In 2019, a delegation of Belgian biotechs participated in an economic mission to China led by H.R.H. Princess Astrid. Co-organized […] December 2, 2020 · Turnstone Communications
    Sponsored

    Long-term loyalty: A Belgian fund’s perspective on Chinese investors

    Over the past few years, an increasing number of European biotechs have been signing deals with Chinese investors. The Chinese […] December 2, 2020 · Turnstone Communications
    News

    eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

    Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Turnstone Communications
    News

    Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

    Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Turnstone Communications
    Article

    A life-changing discovery: CRISPR scientists awarded the 2020 Nobel Prize in Chemistry

    After several years of nominations, Emmanuelle Charpentier and Jennifer Doudna have finally been awarded the 2020 Nobel Prize in Chemistry […] November 4, 2020 · BioVox
    Article

    An insightful solution to eye injections

    Developing new therapies is sometimes not enough: for retinal indications, accurate delivery is key to making a drug work. Lowering […] November 4, 2020 · V-Bio Ventures
    Article

    Vascular dysfunction meets immune suppression

    November 4, 2020 · BioVox
    Article

    New initiative to promote transition to Organ-on-Chip technology

    In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by […] October 29, 2020 · BioVox
    News

    V-Bio Ventures invests in new start-up Animab in a EUR 3.4 million Seed Financing to improve health and performance of livestock animals

    Gent, Belgium, 27 October 2020 – Today V-Bio Ventures announces its investment in Animab, a new venture spin-off from VIB, in a EUR […] October 27, 2020 · V-Bio Ventures
    Article

    Belgium: the number one biotech country in Europe!

    For the third year in a row, Belgium has been ranked the number one country in Europe for biotech! Belgium […] September 30, 2020 · BioVox
    Article

    Get to know Lewis Cantley: winner of the 2020 Dr. Paul Janssen Award

    Every year, the Dr. Paul Janssen Award for Biomedical Research is granted to a scientist who embodies the eponymous man’s […] September 30, 2020 · Janssen Pharmaceutica
    Article

    UAntwerp researchers find cause for mysterious nodding syndrome

    For decades, researchers have been trying to uncover the cause of nodding syndrome, a mysterious and deadly form of epilepsy […] September 30, 2020 · BioVox
    Article

    Can Darwin’s theory explain why we get sick?

    While physicians care for their individual patients and are interested in the factors contributing to the individual’s condition, evolutionary biologists […] September 30, 2020 · V-Bio Ventures
    News

    Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer

    Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Turnstone Communications
    Article

    Countering COVID-19 with llama antibodies

    Last month, VIB spin-off ExeVir Bio raised €23 million to advance a llama-derived antibody against COVID-19. The company is based […] August 31, 2020 · BioVox
    Article

    A novel approach to neurology could bring relief to people in pain

    In August 2020, V-Bio Ventures announced their investment in Biodol Therapeutics, a French start-up looking to make a difference to […] August 31, 2020 · V-Bio Ventures
    Sponsored

    Belgian stem cell company GST bought by German pharmaceutical giant

    The German pharmaceutical giant Boehringer Ingelheim has acquired GST, a stem cell specialist based in Belgium. A part of the […] August 31, 2020 · Turnstone Communications
    Article

    Drug combos: how much is 1 + 1?

    Many of our current antiviral, antibacterial and anti-tumour medications are comprised of combinations of two or three active substances, selected […] August 31, 2020 · V-Bio Ventures
    News

    Biodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures

    V-Bio Ventures, a leading Belgian life sciences VC, invests in Biodol Therapeutics, a French biotech specialized in next-generation chronic pain […] August 31, 2020 · V-Bio Ventures
    News

    Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases

    Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Turnstone Communications
    News

    Lewis Cantley awarded Dr. Paul Janssen Award for Biomedical Research 2020

    Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of […] August 21, 2020 · Janssen Pharmaceutica
    News

    V-Bio invests into ExeVir Bio to accelerate development of new treatment conferring broad protection against Covid-19

    Ghent, Belgium, 28 July 2020 – Today V-Bio Ventures announces its investment in a EUR 23 million Series A financing into ExeVir Bio. […] July 28, 2020 · V-Bio Ventures
    News

    Anacura, a Belgian biotech company, sells stem cell business to Boehringer Ingelheim

    Ghent, Belgium, 27 July 2020 – GST, the stem cell specialist for horses and pets within the Anacura Group, has […] July 27, 2020 · Turnstone Communications
    Sponsored

    Building bigger for Belgium’s maturing biotech scene

    Biotech is booming in Belgium. To support the evolving needs of this world-class ecosystem, the Mariën family initiated and are […] July 7, 2020 · Turnstone Communications
    Article

    VIB: the driving force behind a booming biotech ecosystem

    Since VIB was established, the world class research institute has been led by a duo of managing directors. As Johan […] July 7, 2020 · BioVox
    Article

    The opioid epidemic: solutions to a painful problem

    Opioid misuse is a public health crisis that has resulted in debilitation, deaths, and significant social and economic impact. The […] July 7, 2020 · V-Bio Ventures
    Article

    Colorectal cancer discovery raises hope for microbiome treatment

    A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVox
    News

    Max Planck researchers feed Proteome AI with PharmaFluidics technology

    Micro-chip based µPAC™ LC columns – key component in NATURE study doubling the universe of known proteins across all kingdoms […] June 18, 2020 · Turnstone Communications
    Article

    To prevent another pandemic, we need to improve our relationship with animals

    The new coronavirus did not come as a bolt from the blue. For many years, the World Health Organization (WHO) […] June 8, 2020 · BioVox
    Article

    How changing diets gave rise to the world’s deadliest diseases

    This article was authored by Ward Capoen from V-Bio Ventures. In a recent article, we discussed how the most prescribed […] June 8, 2020 · V-Bio Ventures
    Article

    Fundamental research leads to treatment breakthrough in rare genetic diseases

    A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox
    Article

    Talking T cells with David Masopust

    Immunology is a complex but vitally important branch of the life sciences. Earlier this year, we attended a Keystone Symposia […] June 8, 2020 · BioVox
    News

    PharmaFluidics awarded VLAIO research grant

    Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of […] June 2, 2020 · Turnstone Communications
    Article

    Onno van de Stolpe talks Belgian biotech

    At this year’s Innovation for Health, we sat down for a chat with Onno van de Stolpe. Winner of the […] May 5, 2020 · BioVox
    Article

    Cell therapies: opportunities and challenges

    This article was authored by Christina Takke from V-Bio Ventures. Recent activities in the cell therapy field have prompted many […] May 5, 2020 · V-Bio Ventures
    Article

    TheSocialMedwork: equal access to medicines for everyone, everywhere

    We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world […] May 5, 2020 · BioVox
    Article

    Belgian clinical trials for COVID-19

    With COVID-19 cases soaring into the millions, and a vaccine still a ways off, patients are desperate for a treatment. […] May 5, 2020 · BioVox
    News

    BioVox: the global network for Belgian life sciences turns five and launches a new website!

    May 4, 2020 · Turnstone Communications
    Article

    Potential impact of the corona crisis on the life sciences industry

    This article was authored by Christina Takke from V-Bio Ventures Over the past few months, every news headline has focused […] March 26, 2020 · V-Bio Ventures
    Article

    University Hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    University Hospital Ghent and VIB are assessing a drug called Leukine® to treat patients with respiratory illness associated with COVID-19. Major medical centers in [...] March 25, 2020 · BioVox
    Article

    Why Are Start-Ups Such Hotbeds For Innovation?

    A large proportion of new treatments and life sciences breakthroughs can often be traced back to humble beginnings in a […] January 20, 2020 · V-Bio Ventures
    News

    Biogazelle initiates large-scale testing of COVID-19 in Belgium

    Ghent, Belgium, April 2, 2020 – Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. [...] April 2, 2020 · Turnstone Communications
    News

    ElmediX wants to stop coronavirus by heating patients in a controlled manner

    Mechelen, Belgium, 24 March 2020 – The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive [...] March 24, 2020 · Turnstone Communications
    Article

    Janssen Pharmaceutica and Filliers Distillery make disinfectant hand gel

    Pharmaceutical company Janssen Pharmaceutica and gin distillery Filliers Distillery are making disinfectant hand gel from Sunday. They will distribute it among the Belgian hospitals. March 24, 2020 · Janssen Pharmaceutica
    Article

    Professors of Product Development from UAntwerp are looking at emergency production of mouth masks

    At the University of Antwerp, twelve product developers are working day and night to develop oral masks. “Together with industrial partners, we try to set up an [...] March 24, 2020 · BioVox
    Article

    The long-distance race for a corona vaccine

    Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine. March 24, 2020 · BioVox
    Article

    Gates Foundation commissions large coronavirus study from KU Leuven

    The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports. March 24, 2020 · BioVox
    Article

    VIB achieves important milestone in the development of a COVID-19 drug

    Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). [...] March 24, 2020 · BioVox
    Article

    Augustine Therapeutics: bridging the valley of death with VIB Discovery Sciences

    Augustine Therapeutics is one of VIB’s latest spinoffs, developing a first-in-class drug for Charcot-Marie-Tooth disease. The company recently announced a seed-funding [...] February 26, 2020 · V-Bio Ventures
    Article

    Why everyone needs to be a part of the CRISPR conversation

    With the soaring cost of drugs for rare indications, many biotech and pharmaceutical companies are focusing R&D efforts on orphan diseases. Will the pendulum swing back towards more common maladies? February 26, 2020 · BioVox
    Article

    Belgian initiatives boosting animal-free innovation

    Animals have been used throughout history to understand human physiology and to resolve scientific questions related to health and disease. Nowadays, however, both scientists [...] February 26, 2020 · BioVox
    News

    Montis Biosciences launched with €8.4 million seed financing and a novel approach to immuno-oncology

    Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages [...] February 20, 2020 · Turnstone Communications
    Sponsored

    Inari: shaking things up in the agriculture business

    Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech [...] February 12, 2020 · Turnstone Communications
    News

    PharmaFluidics announces product range extension for its µPACᵀᴹ chromatography chips to serve new biopharma markets

    PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC). [...] February 10, 2020 · Turnstone Communications
    Article

    Predictions for Belgian Biotech in 2020

    With the Belgian biotech landscape blooming, BioVox reached out to some of the investors in our network to see what their predictions are for the coming year. From trends to companies to keep an eye on, here’s their take on 2020! January 22, 2020 · BioVox
    Article

    Battling antibiotic resistance: new strategy targets bacterial slime

    Researchers have developed a new antibacterial strategy that weakens bacteria by preventing them from cooperating. The method involves attacking the protective biofilm [...] January 22, 2020 · BioVox
    Article

    Signposts inspired by bat sonar improve self-driving robots

    To improve sonar navigation systems used by self-driving robots, researchers from Belgium, The Netherlands and Germany have turned to nature for an ingenious solution. [...] January 22, 2020 · BioVox
    News

    V-Bio Ventures invests in RootWave in a EUR 6.5 M Series A financing to develop and market electrical weed killing solutions

    Today V-Bio Ventures announces its investment in RootWave, a pioneer in electrical weed killing solutions. RootWave secured ca. EUR 6.5m in a Series A investment round [...] January 20, 2020 · V-Bio Ventures
    Article

    How business models shaped our current drug development trends

    December 17, 2019 · V-Bio Ventures
    News

    V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases

    Ghent, Belgium, December 16 2019 – Today V-Bio Ventures announces its investment in Augustine Therapeutics, a new venture developing innovative […] December 16, 2019 · V-Bio Ventures
    Article

    New immune system gene discovered in a Flemish boy

    Researchers studying a rare disease have identified a new gene responsible for human immune system regulation. An international collaboration combined […] November 26, 2019 · BioVox
    Article

    Could tick saliva help save lives?

    The biotech Bioxodes is using a molecule derived from tick saliva to stop blood clots. The Walloon company is focused […] January 23, 2020 · BioVox
    Article

    Magic mushrooms in modern medicine

    This article was authored by Katja Rosenkranz from V-Bio Ventures. More than 75 years after the initial discovery of lysergic acid […] November 26, 2019 · V-Bio Ventures
    News

    Caelus Health and Nestlé Health Science sign exclusive global development & option agreement on Caelus’ microbiome-based food supplements

    PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early […] November 25, 2019 · BioVox
    Article

    Combining disciplines for a simple sampling solution

    Novosanis have been able to achieve great success with their clever yet simple urine sampling solution Colli-Pee® [...] November 25, 2019 · BioVox
    Sponsored

    Pulsify Medical to develop a wearable heart monitor patch

    Pulsify Medical, a joint imec and KU Leuven spin-off, has closed a seed funding round of €2.6 million. The investment, […] October 24, 2019 · Turnstone Communications
    Sponsored

    A bridge from East to West: linking Chinese and European biotech

    There are two main reasons why a European company might want to establish official links with a Chinese investor: funding, […] December 1, 2020 · Turnstone Communications
    Article

    The 2019 Nobel Prize in Medicine: How do cells adapt to changing oxygen levels?

    The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza. Their discoveries have [...] October 24, 2019 · BioVox
    Article

    Mining the microbiome for sustainable agriculture solutions

    In this month’s article we take a look at Aphea.Bio, a V-Bio Ventures portfolio company. This startup is developing microbiome […] October 24, 2019 · V-Bio Ventures
    News

    Ovizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation

    Brussels, Belgium 22/10/2019 – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today […] October 22, 2019 · Turnstone Communications
    News

    Prof. Matthias Mann joins PharmaFluidics Advisory Board

    Ghent, Belgium – October 22, 2019 – PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPACTM micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board. October 22, 2019 · Turnstone Communications
    News

    Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

    Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body Leuven, Belgium, […] October 14, 2019 · Turnstone Communications
    Article

    Closing the gender gap in biotech funding: a follow-up study

    This article was authored by Christina Takke from V-Bio Ventures. In this follow-up to a previous VC Views article, V-Bio […] September 24, 2019 · V-Bio Ventures
    Article

    HIV breakthrough at UZ Gent leads to new hope for a cure

    When patients take HIV medication, a small amount of the virus nonetheless stays hidden in the body, preventing a cure. […] September 23, 2019 · BioVox
    Article

    Three business strategy tips to help your company grow

    Turnstone Communications, the driving force behind BioVox news, is a consultancy agency catering to life sciences companies. Lending a hand […] September 23, 2019 · BioVox
    Sponsored

    Fresh insights into the future of cell therapy

    The first edition of Science for health was held in the heart of Brussels on September 11 with a focus […] September 23, 2019 · BioVox
    Article

    Galapagos-Gilead billion-dollar deal: beyond the numbers

    Last month, Galapagos sealed a 5-billion-dollar deal with Gilead. Now that the dust has started to settle, we’re taking a […] August 27, 2019 · BioVox
    Sponsored

    Why events are important for creating connections in the life sciences

    Collaboration is vital for science. Without cross-pollination of ideas and talent, progress would be excruciatingly slow in both industry and academia. [...] August 27, 2019 · BioVox
    Article

    Meet the men who unraveled the mystery of protein folding

    Franz-Ulrich Hartl and Arthur Horwich have been named the winners of the 2019 Dr. Paul Janssen Award for Biomedical Research. […] August 27, 2019 · Janssen Pharmaceutica
    Article

    The million-dollar question: How much do you charge for a lifesaving drug?

    The newest generation of ground-breaking gene therapy drugs, Zolgensma and Zynteglo, come with eye-catching price tags [...] August 26, 2019 · V-Bio Ventures
    Article

    How do we reduce the high cost of clinical trials?

    Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. [...] July 18, 2019 · V-Bio Ventures
    Sponsored

    Living on the edge: the challenge of doing things differently in cell therapy

    Belgian company Celyad is a trailblazer in oncology: its T cell therapies based on NK receptors are cutting edge even […] July 17, 2019 · BioVox
    News

    Gilead and Galapagos enter into transformative research and development collaboration

    Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment Gilead Gains Access to Galapagos’ Differentiated Drug Discovery […] July 15, 2019 · BioVox
    Article

    Solving food waste one StixFresh sticker at a time

    Food waste is a major global issue exacerbated by premature fruit spoilage. A US company, StixFresh, is working together with VIB-KU Leuven Prof Patrick Van Dijck [...] July 15, 2019 · BioVox
    Sponsored

    WELBIO joins ranks with celebrities after a new bacterium is named after the institute

    WELBIO has received a truly unique form of acknowledgement: a newly discovered bacterium has been named after the research institute. […] July 10, 2019 · Turnstone Communications
    News

    Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

    Ghent, Belgium, and Dresden, Germany – 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH […] July 3, 2019 · Turnstone Communications
    Article

    Edible antibodies to prevent and treat gut diseases

    Belgian researchers have developed edible antibodies that can prevent gut bacterial infections. Normally antibodies need to be injected, but the […] June 27, 2019 · BioVox

    AN INITIATIVE OF Turnstone communications logo

    In addition to essential cookies, the BioVox website uses optional cookies to improve your experience. These are only placed with your explicit consent.

    Read MoreCookie settings Reject
    Accept all
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

    Analytics

    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

    Advertisement

    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

    Save & Accept

    Subscribe to our newsletter

    You've successfully subscribed